EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expression of GPR34 in microglia remains stable in human Alzheimer’s disease

Sophie Seiffer, Jonas Rotter, Jana Brendler, Albert Ricken, Zoe Detzer, Max Braune, Torsten Schöneberg, Angela Schulz, Karsten Winter, Ingo Bechmann

Acta Neuropathologica · 15.06.2026 · 151 (1)

DOI: 10.1007/s00401-026-03035-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica, online erschienen am 15.06.2026. Verfasst von Sophie Seiffer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Anatomy, Faculty of Medicine, Leipzig University, Liebigstraße 13, 04103, Leipzig, Germany. sophie.seiffer@medizin.uni-leipzig.de. Hauptthemen laut MEDLINE: Microglia, Alzheimer Disease, Temporal Lobe, Receptors, Lysophospholipid. Die Arbeit nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), Germany´s Excellence Strategy, Faculty of Medicine, Leipzig University, Universität Leipzig.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microglia are the resident immune cells of the human central nervous system and play key roles in development, homeostasis, and disease. These functions are mediated by a broad repertoire of cell-surface receptors, including G protein-coupled receptors such as the ADP receptor P2Y12 and GPR34, a receptor for lysophosphatidylserine. While GPR34 deficiency has been linked to impaired microglial phagocytosis, its regulation in relation to amyloid-β (Aβ) and tau pathology in Alzheimer’s disease (AD) remains unclear. We performed a quantitative analysis of microglial density, morphology, and GPR34 expression in the medial temporal lobe cortex (MTLC) of elderly human body and tissue donors across the AD spectrum. Using fluorescence in situ hybridization and immunolabeling, we analyzed 187,670 microglial cells and correlated microglial parameters with the severity and spatial proximity of Aβ plaques and tau inclusions. In parallel, we analyzed human single-nucleus RNA sequencing data from 236,002 cells to assess GPR34 expression across microglial subtypes, brain regions, and neuropathological stages. Microglial density and overall morphology in the MTLC were largely preserved, independent of local Aβ or hyperphosphorylated tau burdens. Apart from a moderate shortening of microglial processes in the immediate vicinity of Aβ plaques, no consistent pathology-associated morphological changes were detected. GPR34 expression showed pronounced cell-to-cell variability and differed across microglial subtypes and brain regions, but neither expression intensity nor the proportion of GPR34-positive microglia correlated consistently with Braak stage or Thal phase. These findings suggest that GPR34 regulation in human microglia is highly context-dependent and shaped by regional and cellular heterogeneity rather than AD-associated pathology alone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaAlzheimer DiseaseTemporal LobeReceptors, LysophospholipidHumansAged, 80 and overFemaleMaletau ProteinsAgedPlaque, AmyloidAmyloid beta-Peptides

Stichwörter der Autor:innen

Amyloid beta plaquesGliaNeurodegenerative diseaseNeurofibrillary tanglesNeuropathology

Substanzen

tau ProteinsG-protein-coupled receptor 34Amyloid beta-PeptidesReceptors, Lysophospholipid

Autor:innen und Institutionen

  • Institute of Anatomy, Faculty of Medicine, Leipzig University, Liebigstraße 13, 04103, Leipzig, Germany. sophie.seiffer@medizin.uni-leipzig.de.
  • Institute of Anatomy, Faculty of Medicine, Leipzig University, Liebigstraße 13, 04103, Leipzig, Germany.
  • Paul Flechsig Institute of Neuropathology, University Hospital Leipzig, Leipzig, Germany.
  • Rudolf Schönheimer Institute of Biochemistry, Faculty of Medicine, Leipzig University, Leipzig, Germany.
  • Department of Biochemistry, School of Medicine, University of Global Health Equity (UGHE), Kigali, Rwanda.
  • LeiCeM - Leipzig Center of Metabolism, Leipzig University, Leipzig, Germany.

Förderung

  • Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), Germany´s Excellence Strategy
  • Faculty of Medicine, Leipzig University
  • Universität Leipzig

Zitieren

APA

Seiffer, S., Rotter, J., Brendler, J., Ricken, A., Detzer, Z., Braune, M., Schöneberg, T., Schulz, A., Winter, K., & Bechmann, I. (2026). Expression of GPR34 in microglia remains stable in human Alzheimer’s disease. Acta Neuropathologica, 151(1). https://doi.org/10.1007/s00401-026-03035-0

Vancouver

Seiffer S, Rotter J, Brendler J, Ricken A, Detzer Z, Braune M, et al. Expression of GPR34 in microglia remains stable in human Alzheimer’s disease. Acta Neuropathologica. 2026;151(1). doi:10.1007/s00401-026-03035-0

BibTeX
@article{Seiffer2026,
  author = {Seiffer, Sophie and Rotter, Jonas and Brendler, Jana and Ricken, Albert and Detzer, Zoe and Braune, Max and Schöneberg, Torsten and Schulz, Angela and Winter, Karsten and Bechmann, Ingo},
  title = {Expression of GPR34 in microglia remains stable in human Alzheimer’s disease},
  journal = {Acta Neuropathologica},
  year = {2026},
  volume = {151},
  number = {1},
  doi = {10.1007/s00401-026-03035-0}
}
Kostenlos starten →